Eikon Therapeutics Stock
HealthTechLooking to sell Eikon Therapeutics stock or options?
Eikon Therapeutics is a company that operates a platform for drug discovery and development, aiming to provide innovative treatments for life-threatening diseases. Their platform allows for the precise identification of compound-protein interactions that are typically unidentifiable through traditional assays. It achieves this by directly observing the impact of chemical compounds on the behavior of a wide range of individual proteins within a live cellular environment. This technology enables healthcare companies to leverage otherwise challenging protein classes as potential drug targets.
Schroders Capital, CPP Investments, Innovation Endeavors, Abu Dhabi Investment Authority, Lux Capital, E15 VC, Harel Insurance Investments & Financial Services, UC Investments, EcoR1 Capital, General Catalyst, Resolved Ventures, AME Cloud Ventures, T. Rowe Price Group, StepStone Group, Soros Capital Management, TCG Crossover Management, The Column Group, Horizons Ventures, Khaira Capital, Foresite Capital.